Medical Devices & Diagnostics
Medical devices and diagnostics are the hardware of medicine — implants, surgical robots, imaging, and the tests that decide what treatment follows. Approval and reimbursement matter to the investment case as much as the technology does.
342 stocks
| # | Name |
Funds holding | Growth | Growth % |
Fund value |
|
|---|---|---|---|---|---|---|
| 1 |
1
Johnson & Johnson
JNJ
$610B
| 4,551 | +352 | +8% | $367B |
|
| 2 |
2
Abbott
ABT
$181B
| 3,292 | +108 | +3% | $174B |
|
| 3 |
3
Intuitive Surgical
ISRG
$151B
| 2,420 | +303 | +14% | $173B |
|
| 4 |
4
Stryker
SYK
$112B
| 2,334 | +59 | +3% | $107B |
|
| 5 |
5
Medtronic
MDT
$122B
| 2,320 | +142 | +7% | $105B |
|
| 6 |
6
Danaher
DHR
$163B
| 2,315 | +165 | +8% | $133B |
|
| 7 |
7
Boston Scientific
BSX
$64B
| 1,796 | +80 | +5% | $130B |
|
| 8 |
8
Becton Dickinson
BDX
$52.8B
| 1,554 | +69 | +5% | $51.8B |
|
| 9 |
9
GE HealthCare
GEHC
$31.8B
| 1,339 | +57 | +4% | $33.7B |
|
| 10 |
10
Edwards Lifesciences
EW
$50.8B
| 1,315 | +60 | +5% | $43B |
|
| 11 |
11
Roper Technologies
ROP
$37.8B
| 1,264 | -26 | -2% | $45.4B |
|
| 12 |
12
DuPont de Nemours
DD
$17.8B
| 1,223 | -138 | -10% | $12.8B |
|
| 13 |
13
Agilent Technologies
A
$49.5B
| 1,149 | +106 | +10% | $34.9B |
|
| 14 |
14
Quest Diagnostics
DGX
$26.4B
| 1,051 | +44 | +4% | $18.4B |
|
| 15 |
15
Labcorp
LH
$26.4B
| 1,030 | +17 | +2% | $20.1B |
|
| 16 |
16
Zimmer Biomet
ZBH
$18B
| 950 | -21 | -2% | $17.9B |
|
| 17 |
17
ResMed
RMD
$34.1B
| 948 | -2 | -0.2% | $23.4B |
|
| 18 |
18
Solventum
SOLV
$15B
| 943 | +71 | +8% | $9.99B |
|
| 19 |
19
DexCom
DXCM
$33.1B
| 922 | +11 | +1% | $24.9B |
|
| 20 |
20
Steris
STE
$21.9B
| 897 | +53 | +6% | $23.5B |
|
| 21 |
21
Insulet
PODD
$9.62B
| 834 | +20 | +2% | $20B |
|
| 22 |
22
Waters Corp
WAT
$43.6B
| 808 | +52 | +7% | $21.9B |
|
| 23 |
23
Natera
NTRA
$58.3B
| 786 | +100 | +15% | $30.3B |
|
| 24 |
24
DELISTED
Hologic
HOLX
| 750 | +10 | +1% | $16B |
|
| 25 |
25
Baxter International
BAX
$13.3B
| 712 | -22 | -3% | $10.5B |
|